NLRP3 and atrial fibrillation: Systemic oxidative stress has been identified as a robust biomarker of AF risk, reflecting upstream cardiometabolic burden and serving as a key amplifier of redox-sensitive pathways such as NLRP3 inflammasome activation [42].